Skip to main content
Premium Trial:

Request an Annual Quote

PositiveID Inks Deal for $2.4M in Financing

NEW YORK (GenomeWeb) – PositiveID today announced an agreement with an unidentified institutional investor for $2.4 million in financing. 

Under the terms of the deal, PositiveID will issue a series of 4 percent original issue discount senior secured convertible promissory notes to the investor during a six-month period in a series of six notes. The investor has the right to convert the notes into PositiveID's common shares at a fixed conversion price of $.028 per share, the Delray Beach, Florida-based firm said. 

Proceeds will go toward the development and testing of its Firefly Dx PCR prototype pathogen detection platform and for general working capital. 

Calling the funding "critically important" to the advancement of Firefly DX, PositiveID Chairman and CEO William Caragol said in a statement that the firm plans "to build upon the significant progress we have made and focus on the next phase of our development with the goal of producing a field-testable unit for the large point-of-need detection market." 

Firefly Dx is being developed for rapid and accurate point-of-need diagnostics and is targeted to hospitals, first responders, and other providers. Its applications include lab quality testing; pathogenic organism detection; agricultural and food screening in both domestic sectors and developing countries; and detection of biological agents associated with weapons of mass destruction.  

Earlier this month, PositiveID and GenArraytion reached a deal for the evaluation of GenArraytion's assays on the Firefly DX system.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.